Coris Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 74.81%
- Profit Growth 33.77%
- Ebitda 748.32%
- Net Worth 3.14%
- Total Assets 42.82%
About Coris Chemicals And Pharmaceuticals
Coris Chemicals And Pharmaceuticals Private Limited (CCAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 December 2013 and has a history of 11 years and one month. Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kalpesh Kankotiya and Jitendra Jalodara serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233GJ2013PTC078042
-
Company No.
078042
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Dec 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Coris Chemicals And Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpesh Kankotiya
|
Director | 15-Jun-2018 | Current |
|
Jitendra Jalodara
|
Director | 15-Jun-2018 | Current |
Financial Performance of Coris Chemicals And Pharmaceuticals.
Coris Chemicals And Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 74.81% increase. The company also saw a substantial improvement in profitability, with a 33.77% increase in profit. The company's net worth moved up by a moderate rise of 3.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coris Chemicals And Pharmaceuticals?
In 2021, Coris Chemicals And Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Coris Chemicals And Pharmaceuticals?
Unlock and access historical data on people associated with Coris Chemicals And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coris Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coris Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
